Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions

J Dtsch Dermatol Ges. 2019 Sep;17(9):942-948. doi: 10.1111/ddg.13876. Epub 2019 Jun 18.

Authors

Robin Reschke¹, Maja Mockenhaupt², Jan-Christoph Simon¹, Mirjana Ziemer¹

Affiliations

¹ Department of Dermatology, Venereology and Allergology, Leipzig University Medical Center, Leipzig, Germany.
² Center for the Documentation of Severe Skin Reactions (dZh), Department of Dermatology and Venereology, Freiburg University Medical Center, Freiburg, Germany.

PMID: 31210413
DOI: 10.1111/ddg.13876

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Carcinoma, Renal Cell / drug therapy
Carcinoma, Renal Cell / secondary
Cell Cycle Checkpoints / drug effects
Diagnosis, Differential
Drug Eruptions / diagnosis*
Drug Eruptions / pathology
Humans
Lichenoid Eruptions / diagnosis*
Lichenoid Eruptions / etiology
Lichenoid Eruptions / pathology
Nivolumab / adverse effects*
Skin Diseases, Vesiculobullous / diagnosis
Stevens-Johnson Syndrome / diagnosis
Stevens-Johnson Syndrome / etiology

Substances

Antineoplastic Agents, Immunological
Nivolumab